Petrus Trust Company LTA acquired a new position in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 4,839 shares of the specialty chemicals company's stock, valued at approximately $458,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. US Bancorp DE raised its position in shares of Innospec by 4.2% during the first quarter. US Bancorp DE now owns 5,082 shares of the specialty chemicals company's stock worth $482,000 after acquiring an additional 207 shares during the last quarter. Hsbc Holdings PLC increased its position in Innospec by 2.9% in the first quarter. Hsbc Holdings PLC now owns 7,398 shares of the specialty chemicals company's stock worth $700,000 after purchasing an additional 208 shares during the period. Baird Financial Group Inc. raised its holdings in Innospec by 11.5% during the 1st quarter. Baird Financial Group Inc. now owns 2,170 shares of the specialty chemicals company's stock worth $206,000 after purchasing an additional 223 shares during the last quarter. Gotham Asset Management LLC lifted its position in Innospec by 4.6% during the 4th quarter. Gotham Asset Management LLC now owns 5,684 shares of the specialty chemicals company's stock valued at $626,000 after purchasing an additional 252 shares during the period. Finally, Hancock Whitney Corp boosted its stake in shares of Innospec by 6.8% in the 1st quarter. Hancock Whitney Corp now owns 5,435 shares of the specialty chemicals company's stock valued at $515,000 after purchasing an additional 347 shares during the last quarter. 96.64% of the stock is owned by institutional investors.
Innospec Stock Up 0.7%
IOSP traded up $0.57 during trading on Thursday, hitting $83.65. The company had a trading volume of 189,799 shares, compared to its average volume of 200,084. The company has a market capitalization of $2.08 billion, a PE ratio of 107.24 and a beta of 1.11. Innospec Inc. has a one year low of $74.10 and a one year high of $128.35. The firm's 50-day moving average price is $84.56 and its 200 day moving average price is $88.51.
Innospec (NASDAQ:IOSP - Get Free Report) last released its earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.17 by $0.09. The firm had revenue of $439.70 million for the quarter, compared to analysts' expectations of $440.70 million. Innospec had a return on equity of 10.89% and a net margin of 1.08%.The business's quarterly revenue was up 1.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.39 EPS. Sell-side analysts forecast that Innospec Inc. will post 6.18 earnings per share for the current year.
Analysts Set New Price Targets
Separately, Wall Street Zen raised shares of Innospec from a "hold" rating to a "buy" rating in a research note on Friday, September 5th. One analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of "Strong Buy".
View Our Latest Stock Report on Innospec
About Innospec
(
Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Read More

Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.